GW Pharma CEO explains company's plan for CBD-based epilepsy drug February 24, 2021 admin CBD 0 GW Pharmaceuticals CEO Justin Gover tells Jim Cramer the company plans to launch the first CBD-based epilepsy drug in Europe ‘over the next year or two.’
Be the first to comment